Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Laura T. Pizzi is active.

Publication


Featured researches published by Laura T. Pizzi.


PharmacoEconomics | 2004

A Review of Health-Related Workplace Productivity Loss Instruments

Jennifer H. Lofland; Laura T. Pizzi; Kevin D. Frick

The objective of this review was to identify health-related workplace productivity loss survey instruments, with particular emphasis on those that capture a metric suitable for direct translation into a monetary figure.A literature search using Medline, HealthSTAR, PsycINFO and Econlit databases between 1966 and 2002, and a telephone-administered survey of business leaders and researchers, were conducted to identify health-related workplace productivity measurement survey instruments. This review was conducted from the societal perspective. Each identified instrument was reviewed for the following: (i) reliability; (ii) content validity; (iii) construct validity; (iv) criterion validity; (v) productivity metric(s); (vi) instrument scoring technique; (vii) suitability for direct translation into a monetary figure; (viii) number of items; (ix) mode(s) of administration; and (x) disease state(s) in which it had been tested.Reliability and validity testing have been performed for 8 of the 11 identified surveys. Of the 11 instruments identified, six captured metrics that are suitable for direct translation into a monetary figure. Of those six, one instrument measured absenteeism, while the other five measured both absenteeism and presenteeism. All of the identified instruments except for one were available as paper, self-administered questionnaires and many were available in languages other than English.This review provides a comprehensive overview of the published, peerreviewed survey instruments available to measure health-related workplace productivity loss. As the field of productivity measurement matures, tools may be developed that will allow researchers to accurately calculate lost productivity costs when performing cost-effectiveness and cost-benefit analyses. Using data captured by these instruments, society and healthcare decision makers will be able to make better informed decisions concerning the value of the medications, disease management and health promotion programmes that individuals receive.


Journal of Occupational and Environmental Medicine | 2003

Health-related workplace productivity measurement: General and migraine-specific recommendations from the ACOEM expert panel

Ronald Loeppke; Pamela A. Hymel; Jennifer H. Lofland; Laura T. Pizzi; Doris L. Konicki; George W. Anstadt; Catherine M. Baase; Joseph Fortuna; Ted Scharf

An establishment of health-related productivity measurements and critical evaluation of health-related productivity tools is needed. An expert panel was created. A literature search was conducted to identify health-related productivity measurement tools. Each instrument was reviewed for: 1) supporting scientific evidence (eg, reliability and validity); 2) applicability to various types of occupations, diseases, and level of severity of disease; 3) ability to translate data into a monetary unit; and 4) practicality. A modified Delphi technique was used to build consensus. The expert panel recommended absenteeism, presenteeism, and employee turnover/replacement costs as key elements of workplace health-related productivity measurement. The panel also recommended that productivity instruments should: 1) have supporting scientific evidence, 2) be applicable to the particular work setting, 3) be supportive of effective business decision-making, and 4) be practical. Six productivity measurement tools were reviewed. The panel recommended necessary elements of workplace health-related productivity measurement, key characteristics for evaluating instruments, and tools for measuring work loss. Continued research, validation, and on-going evaluation of health-related productivity instruments are needed.


Pharmacotherapy | 2012

Relationship Between Potential Opioid-Related Adverse Effects and Hospital Length of Stay in Patients Receiving Opioids After Orthopedic Surgery

Laura T. Pizzi; Richard W. Toner; Kathleen Foley; Erin Thomson; Wing Chow; Myoung Kim; Joseph Couto; Marc B. Royo; Eugene R. Viscusi

To determine whether there is an association between opioid‐related adverse effects and postoperative hospital length of stay (p‐LOS).


American Journal of Medical Quality | 2005

Factors related to physicians' adoption of electronic prescribing: results from a national survey.

Laura T. Pizzi; Dong-Churl Suh; Joseph A. Barone; David B. Nash

Electronic prescribing (E-RX) is a component of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA). The objective of this study was to identify factors related to physicians’ adoption of E-RX for outpatients. This study employed an electronic survey of US physicians who subscribe to the Physicians Online Internet service. Electronic prescribers were compared to traditional prescribers in terms of demographics, practice type and location, technology use, and beliefs about E-RX. A total of 1104 physicians responded, 19% of whom prescribed electronically. Electronic prescribers were more likely to be generalists practicing in academic or publicly funded centers, have fewer years in practice, and work in technology-equipped offices. They also held different beliefs versus traditional prescribers in terms of E-RX limitations and its potential to improve medication safety and prescribing efficiency. In addition to financial incentives established by MMA, adoption can be stimulated by improvements in the technology and on organizational commitment.


Applied Health Economics and Health Policy | 2011

Costs to hospitals of acquiring and processing blood in the US

Richard W. Toner; Laura T. Pizzi; Brian F. Leas; Samir K. Ballas; Alyson Quigley; Neil I. Goldfarb

BackgroundLittle is known about the economics of acquiring and processing the more than 14 million units of red blood cells used annually in the US.ObjectiveTo determine the average price paid by hospitals to suppliers for a unit of red blood cells and to identify cost variations by region and facility type and size. A secondary objective was to examine costs for additional blood components as well as costs for blood-related processes performed by hospitals. Qualitative input was sought to identify potential cost drivers.MethodsA cross-sectional survey was performed of a randomized sample of hospital-based blood bank and transfusion service directors. The survey instrument assessed costs of specific blood components and services as incurred by hospitals. Analysis of variance was performed to test for significant variation in costs for red blood cells by geographic region and division, facility type and bed capacity.ResultsA total of 213 surveys were completed. The mean (SD) acquisition cost for one unit of red blood cells purchased from a supplier (n = 204) was


Surgical Innovation | 2005

Minimally invasive: minimally reimbursed? An examination of six laparoscopic surgical procedures.

Adam R. Roumm; Laura T. Pizzi; Neil I. Goldfarb; Herbert Cohn

US210.74 ± 37.9 and the mean charge to the patient (n = 167) was


International Journal of Radiation Oncology Biology Physics | 2012

Physician Beliefs and Practices for Adjuvant and Salvage Radiation Therapy After Prostatectomy

Timothy N. Showalter; Nitin Ohri; Kristopher G. Teti; Kathleen Foley; Scott W. Keith; Edouard J. Trabulsi; Adam P. Dicker; Jean H. Hoffman-Censits; Laura T. Pizzi; Leonard G. Gomella

US343.63 ± 135. There was significant statistical variation in acquisition cost by US census region (p < 0.0001) and division (p < 0.0001). Teaching hospitals were more likely to receive volume discounts than other facility types. The mean prices paid per unit for fresh frozen plasma (n = 167) and apheresis platelets (n = 153) were


Annals of Internal Medicine | 2014

Cost-Effectiveness of Allopurinol and Febuxostat for the Management of Gout

Eric Jutkowitz; Hyon K. Choi; Laura T. Pizzi; Karen M. Kuntz

US60.70 ± 20 and


Disease Management & Health Outcomes | 2005

Work Loss, Healthcare Utilization, and Costs among US Employees with Chronic Pain

Laura T. Pizzi; Chureen T. Carter; Jamie Howell; Susan M. Vallow; Albert Crawford; Evan D. Frank

US533.90 ± 69, respectively. The median cost for mandated screening performed onsite (n = 56) was


Journal of Aging Research | 2012

Cost Effectiveness of a Home-Based Intervention That Helps Functionally Vulnerable Older Adults Age in Place at Home

Eric Jutkowitz; Laura N. Gitlin; Laura T. Pizzi; Edward Lee; Marie P. Dennis

US50.00 ± 120 and the median storage and retrieval cost (n = 46) was

Collaboration


Dive into the Laura T. Pizzi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Benjamin E. Leiby

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

E. Jutkowitz

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

Jason J. Schafer

Thomas Jefferson University

View shared research outputs
Researchain Logo
Decentralizing Knowledge